140 related articles for article (PubMed ID: 38145907)
21. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
22. Primary multiple clear cell variant urothelial carcinomas of urinary bladder: a rare case report.
Zhang Y; Huang J; Feng H; Tang Y
Int J Clin Exp Pathol; 2014; 7(6):3385-8. PubMed ID: 25031765
[TBL] [Abstract][Full Text] [Related]
23. A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma.
Leivo MZ; Elson PJ; Tacha DE; Delahunt B; Hansel DE
Pathology; 2016 Oct; 48(6):543-9. PubMed ID: 27594510
[TBL] [Abstract][Full Text] [Related]
24. Inverted variant of urothelial carcinoma of the urinary bladder: a report of three cases and a proposal for a new clinicopathologic entity.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):766-70. PubMed ID: 23573325
[TBL] [Abstract][Full Text] [Related]
25. Sarcomatoid carcinoma of the urinary bladder: a case report with immunohistochemical and molecular genetic analysis.
Terada T
Med Oncol; 2010 Jun; 27(2):547-53. PubMed ID: 19521796
[TBL] [Abstract][Full Text] [Related]
26. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.
Gonzalez-Roibon N; Albadine R; Sharma R; Faraj SF; Illei PB; Argani P; Ertoy D; Allaf ME; Netto GJ
Hum Pathol; 2013 Dec; 44(12):2651-7. PubMed ID: 24071011
[TBL] [Abstract][Full Text] [Related]
27. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK
Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871
[TBL] [Abstract][Full Text] [Related]
28. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
[TBL] [Abstract][Full Text] [Related]
29. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.
Perrino CM; Eble J; Kao CS; Whaley RD; Cheng L; Idrees M; Hashemi-Sadraei N; Monn MF; Kaimakliotis HZ; Bandali E; Grignon D
Hum Pathol; 2019 Aug; 90():27-36. PubMed ID: 31054897
[TBL] [Abstract][Full Text] [Related]
30. Clear cell urothelial carcinoma of the urinary bladder - a rare pathological entity. A case report and a systematic review of the literature.
Mihai I; Taban S; Cumpanas A; Olteanu EG; Iacob M; Dema A
Bosn J Basic Med Sci; 2019 Nov; 19(4):400-403. PubMed ID: 30957722
[TBL] [Abstract][Full Text] [Related]
31. High-grade Urothelial Carcinoma with Malignant Melanocytic Differentiation.
Xu H; Genega EM; Zhuang L; Zhou M
Int J Surg Pathol; 2021 Oct; 29(7):794-797. PubMed ID: 33733892
[TBL] [Abstract][Full Text] [Related]
32. PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract.
Albadine R; Schultz L; Illei P; Ertoy D; Hicks J; Sharma R; Epstein JI; Netto GJ
Am J Surg Pathol; 2010 Jul; 34(7):965-9. PubMed ID: 20463571
[TBL] [Abstract][Full Text] [Related]
33. High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer.
Varma M; Morgan M; Amin MB; Wozniak S; Jasani B
Histopathology; 2003 Feb; 42(2):167-72. PubMed ID: 12558749
[TBL] [Abstract][Full Text] [Related]
34. Rare Plasmacytoid Urothelial Carcinoma of the Bladder: Two Case Reports.
Devrim T; Atac F; Altunkaya C; Ozbek A; Ozdemir G; Eryol M
Urol J; 2019 Feb; 16(1):86-88. PubMed ID: 29781067
[TBL] [Abstract][Full Text] [Related]
35. GATA3 expression in clear cell adenocarcinoma of the lower urinary tract: a potential diagnostic pitfall.
Akgul M; Humble R; Osme A; Yuce S; Kocak EN; Najafzadeh P; Sangoi A; Pattnaik N; Mishra S; Sharma S; Shaker N; Kaushal S; Baisakh M; Lightle AR; Balzer BL; Xiao GQ; MacLennan GT; Osunkoya AO; Parwani A; Cheng L; Bellizzi A; Mohanty SK
Diagn Pathol; 2022 Nov; 17(1):87. PubMed ID: 36320040
[TBL] [Abstract][Full Text] [Related]
36. Urothelial carcinoma with abundant myxoid stroma.
Tavora F; Epstein JI
Hum Pathol; 2009 Oct; 40(10):1391-8. PubMed ID: 19535127
[TBL] [Abstract][Full Text] [Related]
37. Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression.
Iczkowski KA; Shanks JH; Allsbrook WC; Lopez-Beltran A; Pantazis CG; Collins TR; Wetherington RW; Bostwick DG
Histopathology; 1999 Aug; 35(2):150-6. PubMed ID: 10460660
[TBL] [Abstract][Full Text] [Related]
38. Clear cell carcinoma of the bladder in a patient with a earlier clear cell renal cell carcinoma: a case report with morphologic, immunohistochemical, and cytogenetical analysis.
Rotellini M; Fondi C; Paglierani M; Stomaci N; Raspollini MR
Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):396-9. PubMed ID: 20216403
[TBL] [Abstract][Full Text] [Related]
39. Plasmacytoid urothelial carcinoma of the bladder.
Lopez-Beltran A; Requena MJ; Montironi R; Blanca A; Cheng L
Hum Pathol; 2009 Jul; 40(7):1023-8. PubMed ID: 19297008
[TBL] [Abstract][Full Text] [Related]
40. Urothelial Carcinoma With Villoglandular Differentiation: A Rare Entity.
Mitra S; Sundaram AK; Gupta K; Devana SK
Int J Surg Pathol; 2016 Jun; 24(4):356-9. PubMed ID: 26721305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
